Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2001;77:371-378; doi:10.1136/pmj.77.908.371
© 2001 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgrad Med J 2001;77:371-378 ( June )

Review

Alternative opioids to morphine in palliative care: a review of current practice and evidence

M Barnett

Walsgrave Hospital, Coventry and University of Warwick

Correspondence to: Dr M Barnett, Centre for Primary Health Care Studies, University of Warwick, Coventry CV4 7AL, UK

Submitted 8 May 2000; Accepted 31 October 2000

The first 150 words of the full text of this article appear below.

    Introduction

This is a review of current practice of opioid use in palliative care, conducted from the perspective of a practising clinician working in the increasingly complex area of symptom control. In examining alternative opioids to morphine, choice and availability of different drugs reflect the UK perspective. Some drugs or formulations may not be available elsewhere, but the principles discussed may hopefully still be applied.

The aims of this paper are several-fold:


(1)   To present an overview of available opioids.
(2)   To consider factors affecting possible choice of opioid---with particular reference to the palliative care setting.
(3)   To consider availability and limitations of current data which may affect evidence based decisions.
(4)   To comment on areas of interest for future clinical trials.


    Terms of reference

OPIOID RECEPTORS AND EFFECTS
There are three main classes of opioid receptor: mu, kappa, and delta (table 1), responsible for differing opioid effects. Opioid drugs vary in their receptor affinity, thus affecting their principal actions (table 2). The main site of action is the mu receptor, but some opioids have more complex activity.

Table Removed (Available Only in the Full Text)


Table Removed (Available Only in the Full Text)

SIDE EFFECTS OF OPIOIDS
Side effects are common to all opioids, although to differing degrees.

  • Sedation
  • Hallucinations
  • Constipation
  • Nausea/vomiting
  • Urinary retention
  • Myoclonus
  • Paradoxical pain
  • . . . [Full text of this article]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Narabayashi, M., Saijo, Y., Takenoshita, S., Chida, M., Shimoyama, N., Miura, T., Tani, K., Nishimura, K., Onozawa, Y., Hosokawa, T., Kamoto, T., Tsushima, T., Advisory Committee for Oxycodone Study, (2008). Opioid Rotation from Oral Morphine to Oral Oxycodone in Cancer Patients with Intolerable Adverse Effects: An Open-Label Trial. Jpn J Clin Oncol 38: 296-304 [Abstract] [Full Text]  
  • Thulasimani, M, Ramaswamy, S (2002). The role of tricyclic antidepressants and tramadol in palliative care Author's reply. Postgrad. Med. J. 78: 124-124 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.